文献速递外周动脉疾病

血管腔内手术未减轻衰弱对保肢和生存的不利影响

Endovascular surgery does not mitigate the adverse effects of frailty on the risk of losing life or limb.
PubMed 文献 · J Vasc Surg · 2025-07-07

基于VQI-Medicare链接数据库纳入2011至2015年首次接受腹股沟下开放或腔内血运重建的27200例患者,用VQI风险分析指数(RAI)将衰弱分为RAI≥37与RAI<37两组。结果显示衰弱患者死亡率和截肢无生存率显著更差,且开放与腔内两种入路下衰弱与术式的交互项均不显著,腔内入路并未抵消衰弱的不良影响。

要点

  • 衰弱患者4年死亡与截肢无生存显著更差,腔内入路未减轻该风险。
  • CLTI衰弱患者截肢HR 1.36、MALE HR 1.09、死亡HR 2.70。
  • 间歇性跛行中衰弱与死亡相关(HR 3.05),与MALE无关。

核心结论

  • 腔内入路未减轻衰弱对生存与保肢结局的不利影响,提示需筛查衰弱并据此调整治疗与预期。

研究设计与样本

  • 回顾性队列研究,查询VQI-Medicare链接的VISION数据库,纳入2011至2015年首次腹股沟下开放或腔内手术患者n=27,200。
  • 衰弱用VQI风险分析指数(RAI)测量,分为衰弱(RAI≥37)与非衰弱(RAI<37)。
  • 主要终点为4年死亡与主要不良肢体事件(MALE,大截肢和/或再干预)。
  • 采用Kaplan-Meier分析与多因素Cox回归,含交互项并按间歇性跛行或慢性肢体威胁性缺血(CLTI)分层。

主要发现

  • 衰弱患者死亡率与截肢无生存显著更差,衰弱与非衰弱患者腔内优先入路后生存均更差(log-rank P < .001)。
  • CLTI衰弱患者截肢风险升高(HR 1.36;95%CI 1.18-1.56;P < .0001)。
  • CLTI衰弱患者MALE风险升高(HR 1.09;95%CI 1-1.19;P = .049)、死亡风险升高(HR 2.70;95%CI 2.51-2.89;P < .0001)。
  • CLTI腔内入路呈现类似的不良结局模式,但交互项均不显著,衰弱与入路效应互不影响。
  • 跛行患者中衰弱与死亡升高相关(HR 3.05;95%CI 2.40-3.86;P < .0001)但与MALE无关,腔内入路与MALE升高相关而与截肢无关,交互项仍不显著。

关键数值与推荐

  • 衰弱定义:RAI≥37为衰弱,RAI<37为非衰弱。
  • CLTI衰弱患者截肢HR 1.36(95%CI 1.18-1.56;P < .0001)。
  • CLTI衰弱患者MALE HR 1.09(95%CI 1-1.19;P = .049)。
  • CLTI衰弱患者死亡HR 2.70(95%CI 2.51-2.89;P < .0001)。
  • 跛行衰弱患者死亡HR 3.05(95%CI 2.40-3.86;P < .0001)。

临床怎么用

  • 对腹股沟下血运重建患者应常规进行衰弱筛查(如RAI),不应默认腔内入路可抵消衰弱风险。
  • 依据衰弱状态与CLTI或跛行的不同风险调整治疗策略并管理患者对保肢与生存的预期。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Evidence behind frail patients preferentially undergoing minimally invasive endovascular interventions for peripheral arterial disease remains sparse; thus, we evaluated the association of frailty and revascularization-approach with long-term mortality and major adverse limb events (MALEs). METHODS: The Vascular Quality Initiative-Medicare-linked Vascular Implant Surveillance and Interventional Outcomes Network databases were queried for patients who had their first infrainguinal open or endovascular (endo) procedure between 2011 and 2015 (n = 27,200). Frailty was measured using the Vascular Quality Initiative Risk Analysis Index (RAI) and dichotomized into frail (RAI ≥ 37) and nonfrail (RAI < 37). The primary end points were 4-year mortality and MALE (major amputation and/or reintervention). Associations of frailty and approach were estimated using Kaplan-Meier analysis and multivariable Cox hazards regression using an interaction term and stratified by whether the procedure was performed for claudication or chronic-limb threatening ischemia (CLTI). RESULTS: Frail patients experienced significantly worse mortality and amputation-free survival, but both frail and nonfrail patients experienced worse survival after an endovascular first approach (both log-rank P < .001). In adjusted Cox regression, frail patients with CLTI were at significantly increased risk of amputation (hazard ratio [HR], 1.36; 95% confidence interval [CI], 1.18-1.56; P < .0001), MALE (HR, 1.09; 95% CI, 1-1.19; P = .049), and mortality (HR, 2.70; 95% CI, 2.51-2.89; P < .0001) and an endovascular approach for CLTI demonstrated a similar pattern of adverse outcomes. However, interaction terms were not significant; the effects of frailty and approach did not influence each other. In patients with claudication, frailty was associated with increased mortality (HR, 3.05; 95% CI, 2.40-3.86; P < .0001) but not MALE, and an endovascular approach was associated with increased MALE but not amputation; interaction terms were again not significant. CONCLUSIONS: Endovascular approach did not mitigate the adverse effects of frailty on life and limb-related outcomes, thereby underscoring the need for frailty screening and accordingly tailoring treatment and managing expectations given their high mortality risk.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Sorondo SM, Arnow K, Kashikar A, et al. Endovascular surgery does not mitigate the adverse effects of frailty on the risk of losing life or limb. J Vasc Surg. 2025. PMID: 40633790. doi:10.1016/j.jvs.2025.06.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。